Chemo shot straight into tumor could cut side effects
NCT ID NCT07495098
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests injecting the chemotherapy drug cisplatin directly into lung tumors using a thin tube with a camera. The goal is to see if this approach is safe and can kill more cancer cells while causing fewer side effects than standard IV chemo. The study will enroll 12 adults with stage IV non-small cell lung cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cisplatin
- What this could lead to
- If it works, this could point toward a less toxic way to deliver chemotherapy directly into lung tumors, potentially improving treatment outcomes with fewer side effects.
- What could go wrong
- This is a very early Phase 1 trial with only 12 participants, so safety and dosing are still being tested. It may not work as hoped, and there are risks from the procedure itself, such as bleeding or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart drug home in on Hard-to-Treat cancers?
- Can a Two-Drug combo outsmart resistant lung cancer?
- Family support may be key to easing lung cancer surgery stress
- Can a drop of blood predict disease years before it strikes?
- Blood, urine, and stool may hold the key to predicting a serious side effect of lung cancer treatment
- Microwave ablation vs. radiotherapy: which Non-Surgical option works best for early lung cancer?